{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:51:09Z","timestamp":1777330269550,"version":"3.51.4"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,27]]},"DOI":"10.7759\/cureus.107834","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:27:01Z","timestamp":1777328821000},"source":"Crossref","is-referenced-by-count":0,"title":["Zoster-Like Dermatomal Eruption Following Recombinant Zoster Vaccine: A Case Report"],"prefix":"10.7759","author":[{"given":"Reem M","family":"AlZahrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahlam  H","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zubaida H","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal  A","family":"Kokandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawabi M","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_933_22","article-title":"Clinical and epidemiological aspects of herpes zoster disease in a primary care setting in Riyadh, Saudi Arabia: a retrospective cohort study","volume":"11","author":"Binsaeedu AS","year":"2022","unstructured":"Binsaeedu AS, Bajaber AO, Muqrad AG, Alendijani YA, Alkhenizan HA, Alsulaiman TA, Alkhenizan AH. Clinical and epidemiological aspects of herpes zoster disease in a primary care setting in Riyadh, Saudi Arabia: a retrospective cohort study. J Family Med Prim Care. 2022, 11:6433-7. 10.4103\/jfmpc.jfmpc_933_22","journal-title":"J Family Med Prim Care"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.07.036","article-title":"The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region","volume":"25","author":"Nardone A","year":"2007","unstructured":"Nardone A, de Ory F, Carton M, et al.. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine. 2007, 25:7866-72. 10.1016\/j.vaccine.2007.07.036","journal-title":"Vaccine"},{"key":"ref3","article-title":"Shingrix for herpes zoster: a review","volume":"24","author":"Shah RA","year":"2019","unstructured":"Shah RA, Limmer AL, Nwannunu CE, Patel RR, Mui UN, Tyring SK. Shingrix for herpes zoster: a review. Skin Therapy Lett. 2019, 24:5-7.","journal-title":"Skin Therapy Lett"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1495565","article-title":"Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention","volume":"17","author":"Lecrenier N","year":"2018","unstructured":"Lecrenier N, Beukelaers P, Colindres R, et al.. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention. Expert Rev Vaccines. 2018, 17:619-34. 10.1080\/14760584.2018.1495565","journal-title":"Expert Rev Vaccines"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2019.02.009","article-title":"Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine","volume":"59","author":"Heineman TC","year":"2019","unstructured":"Heineman TC, Cunningham A, Levin M. Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine. Curr Opin Immunol. 2019, 59:42-8. 10.1016\/j.coi.2019.02.009","journal-title":"Curr Opin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent AM","year":"2017","unstructured":"Didierlaurent AM, Laup\u00e8ze B, Di Pasquale A, Hergli N, Collignon C, Gar\u00e7on N. Adjuvant system AS01: helping to overcome the challenges of modern vaccines. Expert Rev Vaccines. 2017, 16:55-63. 10.1080\/14760584.2016.1213632","journal-title":"Expert Rev Vaccines"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.34431","article-title":"Reactivation of herpes zoster after recombinant vaccine (Shingrix): a case report","volume":"15","author":"Altukhaim F","year":"2023","unstructured":"Altukhaim F, Mutlaq M, Alghamdi M, Hakami S. Reactivation of herpes zoster after recombinant vaccine (Shingrix): a case report. Cureus. 2023, 15:e34431. 10.7759\/cureus.34431","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2022.2071118","article-title":"Dermatomal rash after Shingrix vaccination: cause or coincidence?","volume":"35","author":"Mittal N","year":"2022","unstructured":"Mittal N, Dhir N, Mittal N. Dermatomal rash after Shingrix vaccination: cause or coincidence?. Proc (Bayl Univ Med Cent). 2022, 35:686-7. 10.1080\/08998280.2022.2071118","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1016672","article-title":"Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China","volume":"11","author":"Zhu Q","year":"2015","unstructured":"Zhu Q, Zheng H, Qu H, et al.. Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China. Hum Vaccin Immunother. 2015, 11:2113-8. 10.1080\/21645515.2015.1016672","journal-title":"Hum Vaccin Immunother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal H","year":"2015","unstructured":"Lal H, Cunningham AL, Godeaux O, et al.. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015, 372:2087-96. 10.1056\/NEJMoa1501184","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-018-0394-4","article-title":"Herpes zoster and diabetes mellitus: a review","volume":"9","author":"Papagianni M","year":"2018","unstructured":"Papagianni M, Metallidis S, Tziomalos K. Herpes zoster and diabetes mellitus: a review. Diabetes Ther. 2018, 9:545-50. 10.1007\/s13300-018-0394-4","journal-title":"Diabetes Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/362169-zoster-like-dermatomal-eruption-following-recombinant-zoster-vaccine-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:27:02Z","timestamp":1777328822000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/362169-zoster-like-dermatomal-eruption-following-recombinant-zoster-vaccine-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.107834","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}